QualityStocksNewsBreaks Archives - Page 1000 of 1387

MondayOct 21, 2019 10:14 am

QualityStocksNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Bolsters Research Expertise with Appointment of Chief Scientific Officer Dr. Ari Mackler

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis branded products company in the U.S., this morning announced the addition of Dr. Ari Mackler as its chief scientific officer. Per the update, Dr. Mackler brings 20 years of medical affairs, communications, and research experience in pharmaceutical, healthcare, and consumer goods industries. The position at PLUS will allow Dr. Mackler to pursue research relationships and clinical trials with private partners and academic institutions in an effort to expand consumer understanding of cannabis and the benefits it may provide. “Dr. Mackler has a long history of helping consumer product companies share…

MondayOct 21, 2019 9:39 am

QualityStocksNewsBreaks – Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Achieves Stabilized Production, Sales of Heavy Oil from Asphalt Ridge Facility

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF), a fully integrated surface oil sands clean recovery mining oil company with proprietary technology, today announced that it has achieved stabilized production rates and sales of heavy oil from its Asphalt Ridge Facility in Utah. According to the update, the company has achieved the following since re-commissioning the plant in September 2019: Cumulative sales of 1,000 barrels of heavy oil; stabilized production rate of 200 bbl/per day from the facility’s current daily 12 hour shift; and oil quality (namely, clay percent and oil thickness) to meet the requirements of specific buyers. Production numbers are…

FridayOct 18, 2019 3:16 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Utilizing Artificial Intelligence, Smart Tumor Profiling to Augment Clinical Outcomes

Predictive Oncology (NASDAQ: POAI), a developer of highly adaptable assessment methods for cancer patients to help guide personalized treatments, employs its proprietary smart tumor profiling and artificial intelligence (“AI”) platform to predict tumor drug response and improve clinical outcomes for cancer patients. An article discussing the company’s activities further reads, “Last year, POAI, then known as Precision Therapeutics, formed TumorGenesis to focus on innovative ways to create improved patient-derived (PDx) tumor models. Currently, TumorGenesis is working on developing new techniques for growing tumors in the lab to generate more relevant models of the tumors that can be used to test…

FridayOct 18, 2019 3:11 pm

QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Expanding Commercialization of Wearable Pain-Management Device

Endonovo Therapeutics (OTCQB: ENDV), a commercial-stage developer of noninvasive Electroceutical® therapeutic devices, has completed clinical trials and is currently expanding commercialization of its SofPulse® device that delivers pulsed electromagnetic frequencies for pain management. An article discussing the company reads, “In August, Endonovo announced its Q2 financial results, showing growth in both revenue and gross profits. However, since the economic potential for a safe, nonaddictive alternative to opioids is significant, the company’s continued progress as it reaches developmental and test milestones is clearly the key focus. Over the second quarter of 2019, the company expanded SofPulse® commercialization and announced the first…

FridayOct 18, 2019 3:00 pm

QualityStocksNewsBreaks – Xalles Holdings Inc. (XALL) Becoming Leading Provider of Payment Systems by Acquiring, Mentoring Fintech Firms

Xalles Holdings (OTC: XALL), a business-development company focused on the payment industry and financial technology, is developing a fintech transaction-support strategy through acquisitions and mentoring. An article discussing the company further reads, “Xalles Holdings is working to become the dominant provider of payment systems by acquiring and mentoring select fintech firms with developing revenue streams and opportunities to boost those revenues. The company’s subsidiaries provide or are preparing to provide investment-management capabilities, post-payment auditing using a proprietary software platform, payment-card financial services and rewards programs that include nonprofit fundraising platforms, among other things. . . . ‘The common element .…

FridayOct 18, 2019 2:33 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) DehydraTECH Platform Offers Alternative to Traditional Inhalation

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) innovative DehydraTECH(TM) platform works to deliver chemical compounds to the bloodstream at speeds similar to inhalation methods, offering an alternative to smoking. An article discussing the company further reads, “Lexaria’s noncombustion-based, noninhalation-based delivery method requires no chemicals or additives. . . . ‘We use a patented dehydration synthesis process to combine the nicotine with simple ingredients like sunflower oil in a unique way,’ CEO Chris Bunka told Forbes (http://ibn.fm/uCoMP). ‘It allows for the removal of the bitter taste often associated with nicotine without the need for artificial flavors that are often appealing to children.…

FridayOct 18, 2019 1:52 pm

QualityStocksNewsBreaks – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Establishing Leadership in Booming Hemp-Derived, CBD-Oil Market

Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) is making a name for itself as a market leader while the global hemp-derived CBD oil market is projected to reach $22 billion by 2022 (http://ibn.fm/yPoHn). An article discussing the company reads, “Following the latest strategic partnerships and retail collaborations, the Wildflower Brands CBD-infused products can now be found in 600 locations across America. . . . The marketplace is forecast to explode in the near future, and the entities that have an already well-established and recognizable brand will benefit the most, as McLean stated in a news release. ‘Our strategy is to build off…

FridayOct 18, 2019 1:46 pm

QualityStocksNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Launches Luxury Hemp-Based Product Line

Geyser Brands (TSX.V: GYSR), a global science-led, consumer, health-care company, recently launched a luxury hemp-based product line. An article discussing the company reads, “STōND is a line of 100% natural self-care products formulated with cannabis sativa hemp oil and features a wide range of products such as massage oils, body lotions, body scrubs, lip balms, mud masks, headache roll-ons, pain gels, joint creams, solid face serums and anti-wrinkle serums. . . . In a press release announcing the new line of products, the company noted that hemp is a source of potent polyunsaturated fats that play a key role in…

FridayOct 18, 2019 12:25 pm

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Details New Strategic Plan to Cut Financing Requirements while Preserving Path to Profitability

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organic cannabis, today announced its new strategic plan to reduce its financing requirements while maintaining its path to profitability. Per the update, the company intends to improve agility by reducing capital requirements, establishing a simple way to scale up production as more retail locations open and legal sales increase, and adapting to slower legal market conversion by deferring excess capacity and expenses. TGODF also maintains its objective to become EBITDA and operating cash flow positive by Q2 2020. “These actions are logical next steps in…

FridayOct 18, 2019 10:58 am

QualityStocksNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) Announces Dividend Payment Timing for October 2019 Series “D” Cumulative Redeemable Perpetual Preferred Stock

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, today announced the timing for the payment of its declared regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (NASDAQ: YGYIP) for October 2019. According to the update, the dividend will be paid in cash and will be payable on November 15, 2019, to holders of record as of October 31, 2019. To view the full press release, visit http://ibn.fm/4teXP About Youngevity International Inc. Youngevity International Inc. is a multi-channel lifestyle company operating in three distinct business…

Site Search

Company Search

Category: QualityStocksNewsBreaks